Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Lance Liotta
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Occupations
Devices
Disorders
Chemicals & Drugs
Physiology
Anatomy
Concepts & Ideas
Genes & Molecular Sequences
Objects
Procedures
Sign-in to see full Profile
Network (preview)
140
Petricoin, Emanuel
55
Emmert-Buck, Michael
40
Espina, Virginia
35
Zhuang, Zhengping
34
Stracke, Mary
33
Kohn, Elise
23
Wulfkuhle, Julia
21
Stetler-Stevenson, William
20
Lubensky, Irina
19
Krutzsch, Henry
18
Geho, David
18
Collins, Francis
18
Spiegel, Allen
17
Chandrasekharappa, Settara
17
Guru, Siradanahalli
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Lance Liotta (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Havaleshko Dmytro M; Smith Steven Christopher; Cho HyungJun; Cheon Sooyoung; Owens Charles R; Lee Jae K; Liotta Lance A; Espina Virginia; Wulfkuhle Julia D; Petricoin Emanuel F; Theodorescu Dan
Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.
Neoplasia (New York, N.Y.) 2009;11(11):1185-93.
-
2009: Gulmann Christian; Sheehan Katherine M; Conroy Ronán M; Wulfkuhle Julia D; Espina Virginia; Mullarkey Michelle J; Kay Elaine W; Liotta Lance A; Petricoin Emanuel F
Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer.
The Journal of pathology 2009;218(4):514-9.
-
2009: Grubb Robert L; Deng Jianghong; Pinto Peter A; Mohler James L; Chinnaiyan Arul; Rubin Mark; Linehan W Marston; Liotta Lance A; Petricoin Emanuel F; Wulfkuhle Julia D
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.
Journal of proteome research 2009;8(6):3044-54.
-
2009: Davuluri Geetanjali; Espina Virginia; Petricoin Emanuel F; Ross Mark; Deng Jianghong; Liotta Lance A; Glaser Bert M
Activated VEGF receptor shed into the vitreous in eyes with wet AMD: a new class of biomarkers in the vitreous with potential for predicting the treatment timing and monitoring response.
Archives of ophthalmology 2009;127(5):613-21.
-
2009: Espina Virginia; Wulfkuhle Julia; Liotta Lance A
Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment.
Clinics in laboratory medicine 2009;29(1):1-13.
-
2009: Nijdam A Jasper; Zianni Michael R; Herderick Edward E; Cheng Mark M-C; Prosperi Jenifer R; Robertson Fredika A; Petricoin Emanuel F; Liotta Lance A; Ferrari Mauro
Application of physicochemically modified silicon substrates as reverse-phase protein microarrays.
Journal of proteome research 2009;8(3):1247-54.
-
2009: Wei Bih-Rong; Hoover Shelley B; Ross Mark M; Zhou Weidong; Meani Francesco; Edwards Jennifer B; Spehalski Elizabeth I; Risinger John I; Alvord W Gregory; Quiñones Octavio A; Belluco Claudio; Martella Luca; Campagnutta Elio; Ravaggi Antonella; Dai Ren-Ming; Goldsmith Paul K; Woolard Kevin D; Pecorelli Sergio; Liotta Lance A; Petricoin Emanuel F; Simpson R Mark
Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.
PloS one 2009;4(10):e7670.
-
2009: Espina Virginia; Liotta Lance A; Petricoin Emanuel F
Reverse-phase protein microarrays for theranostics and patient tailored therapy.
Methods in molecular biology (Clifton, N.J.) 2009;520():89-105.
-
2009: Longo Caterina; Patanarut Alexis; George Tony; Bishop Barney; Zhou Weidong; Fredolini Claudia; Ross Mark M; Espina Virginia; Pellacani Giovanni; Petricoin Emanuel F; Liotta Lance A; Luchini Alessandra
Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers.
PloS one 2009;4(3):e4763.
-
2008: Napoletani D; Sauer T; Struppa D C; Petricoin E; Liotta L
Augmented sparse reconstruction of protein signaling networks.
Journal of theoretical biology 2008;255(1):40-52.
-
2008: VanMeter Amy J; Rodriguez Adrianna S; Bowman Elise D; Jen Jin; Harris Curtis C; Deng Jianghong; Calvert Valerie S; Silvestri Alessandra; Fredolini Claudia; Chandhoke Vikas; Petricoin Emanuel F; Liotta Lance A; Espina Virginia
Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.
Molecular & cellular proteomics : MCP 2008;7(10):1902-24.
-
2008: Espina Virginia; Edmiston Kirsten H; Heiby Michael; Pierobon Mariaelena; Sciro Manuela; Merritt Barbara; Banks Stacey; Deng Jianghong; VanMeter Amy J; Geho David H; Pastore Lucia; Sennesh Joel; Petricoin Emanuel F; Liotta Lance A
A portrait of tissue phosphoprotein stability in the clinical tissue procurement process.
Molecular & cellular proteomics : MCP 2008;7(10):1998-2018.
-
2008: Sturgeon Catharine M; Hoffman Barry R; Chan Daniel W; Ch'ng Soo-Ling; Hammond Elizabeth; Hayes Daniel F; Liotta Lance A; Petricoin Emmanuel F; Schmitt Manfred; Semmes O John; Söletormos Györg; van der Merwe Elena; Diamandis Eleftherios P;
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.
Clinical chemistry 2008;54(8):e1-e10.
-
2008: Araujo R P; Petricoin E F; Liotta L A
Critical dependence of blood-borne biomarker concentrations on the half-lives of their carrier proteins.
Journal of theoretical biology 2008;253(3):616-22.
-
2008: Wulfkuhle Julia D; Speer Runa; Pierobon Mariaelena; Laird Julie; Espina Virginia; Deng Jianghong; Mammano Enzo; Yang Sherry X; Swain Sandra M; Nitti Donato; Esserman Laura J; Belluco Claudio; Liotta Lance A; Petricoin Emanuel F
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.
Journal of proteome research 2008;7(4):1508-17.
-
2008: Liotta Lance A; Petricoin Emanuel F
Putting the "bio" back into biomarkers: orienting proteomic discovery toward biology and away from the measurement platform.
Clinical chemistry 2008;54(1):3-5.
-
2008: Luchini Alessandra; Geho David H; Bishop Barney; Tran Duy; Xia Cassandra; Dufour Robert L; Jones Clinton D; Espina Virginia; Patanarut Alexis; Zhou Weidong; Ross Mark M; Tessitore Alessandra; Petricoin Emanuel F; Liotta Lance A
Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation.
Nano letters 2008;8(1):350-61.
-
2008: Sheehan K M; Gulmann C; Eichler G S; Weinstein J N; Barrett H L; Kay E W; Conroy R M; Liotta L A; Petricoin E F
Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition.
Oncogene 2008;27(3):323-31.
-
2008: Speer Runa; Wulfkuhle Julia; Espina Virginia; Aurajo Robyn; Edmiston Kirsten H; Liotta Lance A; Petricoin Emanuel F
Molecular network analysis using reverse phase protein microarrays for patient tailored therapy.
Advances in experimental medicine and biology 2008;610():177-86.
-
2008: Espina Virginia; Wulfkuhle Julia; Calvert Valerie S; Liotta Lance A; Petricoin Emanuel F
Reverse phase protein microarrays for theranostics and patient-tailored therapy.
Methods in molecular biology (Clifton, N.J.) 2008;441():113-28.
-
2008: Rodriguez Adrianna S; Espina Benjamin H; Espina Virginia; Liotta Lance A
Automated laser capture microdissection for tissue proteomics.
Methods in molecular biology (Clifton, N.J.) 2008;441():71-90.
-
2007: Araujo Robyn P; Liotta Lance A; Petricoin Emanuel F
Proteins, drug targets and the mechanisms they control: the simple truth about complex networks.
Nature reviews. Drug discovery 2007;6(11):871-80.
-
2007: Cowen E W; Liu C-W; Steinberg S M; Kang S; Vonderheid E C; Kwak H S; Booher S; Petricoin E F; Liotta L A; Whiteley G; Hwang S T
Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis.
The British journal of dermatology 2007;157(5):946-53.
-
2007: Zhou Jiangbing; Wulfkuhle Julia; Zhang Hao; Gu Peihua; Yang Yanqin; Deng Jianghong; Margolick Joseph B; Liotta Lance A; Petricoin Emanuel; Zhang Ying
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(41):16158-63.
-
2007: Espina Virginia; Heiby Michael; Pierobon Mariaelena; Liotta Lance A
Laser capture microdissection technology.
Expert review of molecular diagnostics 2007;7(5):647-57.
-
2007: VanMeter Amy; Signore Michele; Pierobon Mariaelena; Espina Virginia; Liotta Lance A; Petricoin Emanuel F
Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.
Expert review of molecular diagnostics 2007;7(5):625-33.
-
2007: Liotta Lance A
Multidimensional metamorphosis of biomarker science.
Expert review of molecular diagnostics 2007;7(5):465-7.
-
2007: Belluco Claudio; Petricoin Emanuel F; Mammano Enzo; Facchiano Francesco; Ross-Rucker Sally; Nitti Donato; Di Maggio Cosimo; Liu Chenwei; Lise Mario; Liotta Lance A; Whiteley Gordon
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer.
Annals of surgical oncology 2007;14(9):2470-6.
-
2007: Calvert Valerie S; Collantes Rochelle; Elariny Hazem; Afendy Arian; Baranova Ancha; Mendoza Michael; Goodman Zachary; Liotta Lance A; Petricoin Emanuel F; Younossi Zobair M
A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis.
Hepatology (Baltimore, Md.) 2007;46(1):166-72.
-
2007: Rapkiewicz Amy; Espina Virginia; Zujewski Jo Anne; Lebowitz Peter F; Filie Armando; Wulfkuhle Julia; Camphausen Kevin; Petricoin Emanuel F; Liotta Lance A; Abati Andrea
The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology.
Cancer 2007;111(3):173-84.
-
2007: Lopez Mary F; Mikulskis Alvydas; Kuzdzal Scott; Golenko Eva; Petricoin Emanuel F; Liotta Lance A; Patton Wayne F; Whiteley Gordon R; Rosenblatt Kevin; Gurnani Prem; Nandi Animesh; Neill Samuel; Cullen Stuart; O'Gorman Martin; Sarracino David; Lynch Christopher; Johnson Andrew; Mckenzie William; Fishman David
A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples.
Clinical chemistry 2007;53(6):1067-74.
-
2007: Speer Runa; Wulfkuhle Julia; Espina Virginia; Aurajo Robyn; Edmiston Kirsten H; Liotta Lance A; Petricoin Emanuel F
Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.
Cancer genomics & proteomics 2007;4(3):157-64.
-
2007: Petricoin Emanuel F; Espina Virginia; Araujo Robyn P; Midura Brieanne; Yeung Choh; Wan Xiaolin; Eichler Gabriel S; Johann Donald J; Qualman Stephen; Tsokos Maria; Krishnan Kartik; Helman Lee J; Liotta Lance A
Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival.
Cancer research 2007;67(7):3431-40.
-
2007: Shankavaram Uma T; Reinhold William C; Nishizuka Satoshi; Major Sylvia; Morita Daisaku; Chary Krishna K; Reimers Mark A; Scherf Uwe; Kahn Ari; Dolginow Douglas; Cossman Jeffrey; Kaldjian Eric P; Scudiero Dominic A; Petricoin Emanuel; Liotta Lance; Lee Jae K; Weinstein John N
Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study.
Molecular cancer therapeutics 2007;6(3):820-32.
-
2007: Buckanovich Ronald J; Sasaroli Dimitra; O'Brien-Jenkins Anne; Botbyl Jeffrey; Hammond Rachel; Katsaros Dionysios; Sandaltzopoulos Raphael; Liotta Lance A; Gimotty Phyllis A; Coukos George
Tumor vascular proteins as biomarkers in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(7):852-61.
-
2007: Geho David H; Luchini Alessandra; Garaci Enrico; Belluco Claudio; Petricoin Emanuel; Liotta Lance A
Nanotechnology in clinical proteomics.
Nanomedicine (London, England) 2007;2(1):1-5.
-
2007: Do Thuy-Vy; Symowicz Jay C; Berman David M; Liotta Lance A; Petricoin Emanuel F; Stack M Sharon; Fishman David A
Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
Molecular cancer research : MCR 2007;5(2):121-31.
-
2007: Nijdam A Jasper; Ming-Cheng Cheng Mark; Geho David H; Fedele Roberta; Herrmann Paul; Killian Keith; Espina Virginia; Petricoin Emanuel F; Liotta Lance A; Ferrari Mauro
Physicochemically modified silicon as a substrate for protein microarrays.
Biomaterials 2007;28(3):550-8.
-
2007: Espina Virginia; Wulfkuhle Julia D; Calvert Valerie S; Petricoin Emanuel F; Liotta Lance A
Reverse phase protein microarrays for monitoring biological responses.
Methods in molecular biology (Clifton, N.J.) 2007;383():321-36.
-
2006: Petricoin Emanuel F; Belluco Claudio; Araujo Robyn P; Liotta Lance A
The blood peptidome: a higher dimension of information content for cancer biomarker discovery.
Nature reviews. Cancer 2006;6(12):961-7.
-
2006: Chung Myung-Chul; Popova Taissia G; Millis Bryan A; Mukherjee Dhritiman V; Zhou Weidong; Liotta Lance A; Petricoin Emanuel F; Chandhoke Vikas; Bailey Charles; Popov Serguei G
Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors.
The Journal of biological chemistry 2006;281(42):31408-18.
-
2006: Campbell Michael J; Esserman Laura J; Zhou Yamei; Shoemaker Mark; Lobo Margaret; Borman Elizabeth; Baehner Frederick; Kumar Anjali S; Adduci Kelly; Marx Corina; Petricoin Emanuel F; Liotta Lance A; Winters Mary; Benz Stephen; Benz Christopher C
Breast cancer growth prevention by statins.
Cancer research 2006;66(17):8707-14.
-
2006: Wu Shiaw-Lin; Kim Jeongkwon; Bandle Russell W; Liotta Lance; Petricoin Emanuel; Karger Barry L
Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA).
Molecular & cellular proteomics : MCP 2006;5(9):1610-27.
-
2006: Shi Ying; Chen Ling; Liotta Lance A; Wan Hong-Hui; Rodgers Griffin P
Glia maturation factor gamma (GMFG): a cytokine-responsive protein during hematopoietic lineage development and its functional genomics analysis.
Genomics, proteomics & bioinformatics / Beijing Genomics Institute 2006;4(3):145-55.
-
2006: Tada Yayoi; Riedl Elisabeth; Lowenthal Mark S; Liotta Lance A; Briner David M; Crouch Erika C; Udey Mark C
Identification and characterization of endogenous Langerin ligands in murine extracellular matrix.
The Journal of investigative dermatology 2006;126(7):1549-58.
-
2006: Srinivasan Ramaprasad; Daniels Jasmine; Fusaro Vincent; Lundqvist Andreas; Killian Jonathan K; Geho David; Quezado Martha; Kleiner David; Rucker Sally; Espina Virginia; Whiteley Gordon; Liotta Lance; Petricoin Emmanuel; Pittaluga Stefania; Hitt Ben; Barrett A J; Rosenblatt Kevin; Childs Richard W
Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.
Experimental hematology 2006;34(6):796-801.
-
2006: Terracciano Rosa; Gaspari Marco; Testa Flaviano; Pasqua Luigi; Tagliaferri Pierosandro; Cheng Mark Ming-Cheng; Nijdam A Jasper; Petricoin Emanuel F; Liotta Lance A; Cuda Giovanni; Ferrari Mauro; Venuta Salvatore
Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles.
Proteomics 2006;6(11):3243-50.
-
2006: Buckanovich Ronald J; Sasaroli Dimitra; O'brien-Jenkins Ann; Botbyl Jeffrey; Conejo-Garcia Josè R; Benencia Fabian; Liotta Lance A; Gimotty Phyllis A; Coukos George
Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment.
Cancer biology & therapy 2006;5(6):635-42.
-
2006: Geho David; Cheng Mark Ming-Cheng; Killian Keith; Lowenthal Mark; Ross Sally; Frogale Kristina; Nijdam Jasper; Lahar Nicholas; Johann Don; Herrmann Paul; Whiteley Gordon; Ferrari Mauro; Petricoin Emanuel; Liotta Lance
Fractionation of serum components using nanoporous substrates.
Bioconjugate chemistry 2006;17(3):654-61.
-
2006: Wulfkuhle Julia D; Edmiston Kirsten H; Liotta Lance A; Petricoin Emanuel F
Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.
Nature clinical practice. Oncology 2006;3(5):256-68.
-
2006: Gaspari Marco; Ming-Cheng Cheng Mark; Terracciano Rosa; Liu Xuewu; Nijdam A Jasper; Vaccari Lisa; di Fabrizio Enzo; Petricoin Emanuel F; Liotta Lance A; Cuda Giovanni; Venuta Salvatore; Ferrari Mauro
Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma.
Journal of proteome research 2006;5(5):1261-6.
-
2006: Gulmann C; Sheehan K M; Kay E W; Liotta L A; Petricoin E F
Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.
The Journal of pathology 2006;208(5):595-606.
-
2006: Davidson Ben; Espina Virginia; Steinberg Seth M; Flørenes Vivi Ann; Liotta Lance A; Kristensen Gunnar B; Tropé Claes G; Berner Aasmund; Kohn Elise C
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):791-9.
-
2006: Ménard Cynthia; Johann Donald; Lowenthal Mark; Muanza Thierry; Sproull Mary; Ross Sally; Gulley James; Petricoin Emanuel; Coleman C Norman; Whiteley Gordon; Liotta Lance; Camphausen Kevin
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
Cancer research 2006;66(3):1844-50.
-
2006: Geho David H; Liotta Lance A; Petricoin Emanuel F; Zhao Weidong; Araujo Robyn P
The amplified peptidome: the new treasure chest of candidate biomarkers.
Current opinion in chemical biology 2006;10(1):50-5.
-
2006: Araujo Robyn P; Liotta Lance A
A control theoretic paradigm for cell signaling networks: a simple complexity for a sensitive robustness.
Current opinion in chemical biology 2006;10(1):81-7.
-
2006: Geho David H; Jones Clinton D; Petricoin Emanuel F; Liotta Lance A
Nanoparticles: potential biomarker harvesters.
Current opinion in chemical biology 2006;10(1):56-61.
-
2006: Liotta Lance A; Petricoin Emanuel F
Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold.
The Journal of clinical investigation 2006;116(1):26-30.
-
2006: Espina Virginia; Wulfkuhle Julia D; Calvert Valerie S; VanMeter Amy; Zhou Weidong; Coukos George; Geho David H; Petricoin Emanuel F; Liotta Lance A
Laser-capture microdissection.
Nature protocols 2006;1(2):586-603.
-
2006: Espina Virginia; Milia John; Wu Glendon; Cowherd Stacy; Liotta Lance A
Laser capture microdissection.
Methods in molecular biology (Clifton, N.J.) 2006;319():213-29.
-
2005: Mojica Wilfrido D; Rapkiewicz Amy V; Liotta Lance A; Espina Virginia
Manual exfoliation of fresh tissue obviates the need for frozen sections for molecular profiling.
Cancer 2005;105(6):483-91.
-
2005: Chu Wei-Sing; Liang Qi; Liu Jilan; Wei Min Qi; Winters Mary; Liotta Lance; Sandberg Glenn; Gong Maokai
A nondestructive molecule extraction method allowing morphological and molecular analyses using a single tissue section.
Laboratory investigation; a journal of technical methods and pathology 2005;85(11):1416-28.
-
2005: Conrads Thomas P; Hood Brian L; Petricoin Emmanuel F; Liotta Lance A; Veenstra Timothy D
Cancer proteomics: many technologies, one goal.
Expert review of proteomics 2005;2(5):693-703.
-
2005: Lowenthal Mark S; Mehta Arpita I; Frogale Kristina; Bandle Russell W; Araujo Robyn P; Hood Brian L; Veenstra Timothy D; Conrads Thomas P; Goldsmith Paul; Fishman David; Petricoin Emanuel F; Liotta Lance A
Analysis of albumin-associated peptides and proteins from ovarian cancer patients.
Clinical chemistry 2005;51(10):1933-45.
-
2005: Simpkins Fiona; Czechowicz Josephine A; Liotta Lance; Kohn Elise C
SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.
Pharmacogenomics 2005;6(6):647-53.
-
2005: Gulmann Christian; Espina Virginia; Petricoin Emanuel; Longo Dan L; Santi Mariarita; Knutsen Turid; Raffeld Mark; Jaffe Elaine S; Liotta Lance A; Feldman Andrew L
Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5847-55.
-
2005: Ding Wei; Tang Qian; Espina Virginia; Liotta Lance A; Mauger David T; Mulder Kathleen M
A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.
Cancer research 2005;65(15):6526-33.
-
2005: Belluco Claudio; Mammano Enzo; Petricoin Emanuel; Prevedello Luca; Calvert Valerie; Liotta Lance; Nitti Donato; Lise Mario
Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis.
Clinica chimica acta; international journal of clinical chemistry 2005;357(2):180-3.
-
2005: Speer Runa; Wulfkuhle Julia D; Liotta Lance A; Petricoin Emanuel F
Reverse-phase protein microarrays for tissue-based analysis.
Current opinion in molecular therapeutics 2005;7(3):240-5.
-
2005: Brouwers F M; Petricoin E F; Ksinantova L; Breza J; Rajapakse V; Ross S; Johann D; Mannelli M; Shulkin B L; Kvetnansky R; Eisenhofer G; Walther M M; Hitt B A; Conrads T P; Veenstra T D; Mannion D P; Wall M R; Wolfe G M; Fusaro V A; Liotta L A; Pacak K
Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma.
Endocrine-related cancer 2005;12(2):263-72.
-
2005: Geho David H; Bandle Russell W; Clair Timothy; Liotta Lance A
Physiological mechanisms of tumor-cell invasion and migration.
Physiology (Bethesda, Md.) 2005;20():194-200.
-
2005: Petricoin Emanuel F; Bichsel Verena E; Calvert Valerie S; Espina Virginia; Winters Mary; Young Lynn; Belluco Claudio; Trock Bruce J; Lippman Marc; Fishman David A; Sgroi Dennis C; Munson Peter J; Esserman Laura J; Liotta Lance A
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3614-21.
-
2005: Geho David; Lahar Nicholas; Gurnani Prem; Huebschman Michael; Herrmann Paul; Espina Virginia; Shi Alice; Wulfkuhle Julia; Garner Harold; Petricoin Emanuel; Liotta Lance A; Rosenblatt Kevin P
Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays.
Bioconjugate chemistry 2005;16(3):559-66.
-
2005: Winters Mary E; Mehta Arpita I; Petricoin Emanuel F; Kohn Elise C; Liotta Lance A
Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis.
Cancer research 2005;65(9):3853-60.
-
2005: Iyengar Puneeth; Espina Virginia; Williams Terence W; Lin Ying; Berry David; Jelicks Linda A; Lee Hyangkyu; Temple Karla; Graves Reed; Pollard Jeffrey; Chopra Neeru; Russell Robert G; Sasisekharan Ram; Trock Bruce J; Lippman Marc; Calvert Valerie S; Petricoin Emanuel F; Liotta Lance; Dadachova Ekaterina; Pestell Richard G; Lisanti Michael P; Bonaldo Paolo; Scherer Philipp E
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment.
The Journal of clinical investigation 2005;115(5):1163-76.
-
2005: Sheehan Katherine M; Calvert Valerie S; Kay Elaine W; Lu Yiling; Fishman David; Espina Virginia; Aquino Joy; Speer Runa; Araujo Robyn; Mills Gordon B; Liotta Lance A; Petricoin Emanuel F; Wulfkuhle Julia D
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.
Molecular & cellular proteomics : MCP 2005;4(4):346-55.
-
2005: Stone John H; Rajapakse Vinodh N; Hoffman Gary S; Specks Ulrich; Merkel Peter A; Spiera Robert F; Davis John C; St Clair E William; McCune Joseph; Ross Sally; Hitt Ben A; Veenstra Timothy D; Conrads Thomas P; Liotta Lance A; Petricoin Emanuel F;
A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis.
Arthritis and rheumatism 2005;52(3):902-10.
-
2005: Calvo Katherine R; Liotta Lance A; Petricoin Emanuel F
Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Bioscience reports 2005;25(1-2):107-25.
-
2005: Liotta Lance A; Lowenthal Mark; Mehta Arpita; Conrads Thomas P; Veenstra Timothy D; Fishman David A; Petricoin Emanuel F
Importance of communication between producers and consumers of publicly available experimental data.
Journal of the National Cancer Institute 2005;97(4):310-4.
-
2005: Ménard Cynthia; Susil Robert C; Choyke Peter; Coleman Jonathan; Grubb Robert; Gharib Ahmed; Krieger Axel; Guion Peter; Thomasson David; Ullman Karen; Gupta Sandeep; Espina Virginia; Liotta Lance; Petricoin Emanuel; Fitchtinger Gabor; Whitcomb Louis L; Atalar Ergin; Coleman C Norman; Camphausen Kevin
An interventional magnetic resonance imaging technique for the molecular characterization of intraprostatic dynamic contrast enhancement.
Molecular imaging : official journal of the Society for Molecular Imaging 2005;4(1):63-6.
-
2005: Romeo Martin J; Espina Virginia; Lowenthal Mark; Espina Benjamin H; Petricoin Emanuel F; Liotta Lance A
CSF proteome: a protein repository for potential biomarker identification.
Expert review of proteomics 2005;2(1):57-70.
-
2005: Burke Louise; Flieder Douglas B; Guinee Donald G; Brambilla Elizabeth; Freedman Andrew N; Bennett William P; Jones Raymond T; Borkowski Andrew; Caporaso Neil A; Fleming Marian; Trastek Victor; Pairolero Peter; Tazelaar Henry; Midthun David; Jett James R; Liotta Lance A; Travis William D; Harris Curtis C
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):232-41.
-
2005: Posadas E M; Simpkins F; Liotta L A; MacDonald C; Kohn E C
Proteomic analysis for the early detection and rational treatment of cancer--realistic hope?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(1):16-22.
-
2005: Geho D H; Petricoin E F; Liotta L A; Araujo R P
Modeling of protein signaling networks in clinical proteomics.
Cold Spring Harbor symposia on quantitative biology 2005;70():517-24.
-
2005: Espina Virginia; Geho David; Mehta Arpita I; Petricoin Emanuel F; Liotta Lance A; Rosenblatt Kevin P
Pathology of the future: molecular profiling for targeted therapy.
Cancer investigation 2005;23(1):36-46.
-
2005: Clair Timothy; Koh Eunjin; Ptaszynska Malgorzata; Bandle Russell W; Liotta Lance A; Schiffmann Elliott; Stracke Mary L
L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin.
Lipids in health and disease 2005;4():5.
-
2004: Cowherd Stacy M; Espina Virginia A; Petricoin Emmanuel F; Liotta Lance A
Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays.
Clinical breast cancer 2004;5(5):385-92.
-
2004: Tangrea Michael A; Chuaqui Rodrigo F; Gillespie John W; Ahram Mamoun; Gannot Gallya; Wallis Benjamin S; Best Carolyn J M; Linehan W Marston; Liotta Lance A; Pohida Thomas J; Bonner Robert F; Emmert-Buck Michael R
Expression microdissection: operator-independent retrieval of cells for molecular profiling.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2004;13(4):207-12.
-
2004: Wulfkuhle Julia; Espina Virginia; Liotta Lance; Petricoin Emanuel
Genomic and proteomic technologies for individualisation and improvement of cancer treatment.
European journal of cancer (Oxford, England : 1990) 2004;40(17):2623-32.
-
2004: Rapkiewicz Amy V; Espina Virginia; Petricoin Emanuel F; Liotta Lance A
Biomarkers of ovarian tumours.
European journal of cancer (Oxford, England : 1990) 2004;40(17):2604-12.
-
2004: Ornstein David K; Rayford Walter; Fusaro Vincent A; Conrads Thomas P; Ross Sally J; Hitt Ben A; Wiggins Wesley W; Veenstra Timothy D; Liotta Lance A; Petricoin Emanuel F
Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.
The Journal of urology 2004;172(4 Pt 1):1302-5.
-
2004: Geho David H; Lahar Nicholas; Ferrari Mauro; Petricoin Emanuel F; Liotta Lance A
Opportunities for nanotechnology-based innovation in tissue proteomics.
Biomedical microdevices 2004;6(3):231-9.
-
2004: Berman David M; Wang Yunfei; Liu Zhengyu; Dong Qiong; Burke Lorri-Anne; Liotta Lance A; Fisher Rory; Wu Xifeng
A functional polymorphism in RGS6 modulates the risk of bladder cancer.
Cancer research 2004;64(18):6820-6.
-
2004: Krieg René C; Knuechel Ruth; Schiffmann Elliot; Liotta Lance A; Petricoin Emanuel F; Herrmann Paul C
Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation.
Proteomics 2004;4(9):2789-95.
-
2004: Liotta Lance A; Kohn Elise
Anoikis: cancer and the homeless cell.
Nature 2004;430(7003):973-4.
-
2004: Petricoin Emanuel F; Fishman David A; Conrads Thomas P; Veenstra Timothy D; Liotta Lance A
Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics.
Proteomics 2004;4(8):2357-60.
-
2004: Petricoin Emanuel F; Ornstein David K; Liotta Lance A
Clinical proteomics: Applications for prostate cancer biomarker discovery and detection.
Urologic oncology 2004;22(4):322-8.
-
2004: Espina Virginia; Woodhouse Elisa C; Wulfkuhle Julia; Asmussen Heather D; Petricoin Emanuel F; Liotta Lance A
Protein microarray detection strategies: focus on direct detection technologies.
Journal of immunological methods 2004;290(1-2):121-33.
-
2004: Johann Donald J; McGuigan Michael D; Patel Amit R; Tomov Stanimire; Ross Sally; Conrads Thomas P; Veenstra Timothy D; Fishman David A; Whiteley Gordon R; Petricoin Emanuel F; Liotta Lance A
Clinical proteomics and biomarker discovery.
Annals of the New York Academy of Sciences 2004;1022():295-305.
-
2004: Roberts Elizabeth; Charboneau Lu; Espina Virginia; Liotta Lance; Petricoin Emanuel; Dreher Kevin
Application of laser capture microdissection and protein microarray technologies in the molecular analysis of airway injury following pollution particle exposure.
Journal of toxicology and environmental health. Part A 2004;67(11):851-61.
-
2004: Conrads T P; Fusaro V A; Ross S; Johann D; Rajapakse V; Hitt B A; Steinberg S M; Kohn E C; Fishman D A; Whitely G; Barrett J C; Liotta L A; Petricoin E F; Veenstra T D
High-resolution serum proteomic features for ovarian cancer detection.
Endocrine-related cancer 2004;11(2):163-78.
-
2004: Zhou Ming; Lucas David A; Chan King C; Issaq Haleem J; Petricoin Emanuel F; Liotta Lance A; Veenstra Timothy D; Conrads Thomas P
An investigation into the human serum "interactome".
Electrophoresis 2004;25(9):1289-98.
-
2004: Hasan Rani K; Wulfkuhle Julia D; Liotta Lance A; Petricoin Emanuel F
STUDENTJAMA. Molecular technologies for personalized cancer management.
JAMA : the journal of the American Medical Association 2004;291(13):1644-5.
-
2004: Petricoin Emanuel F; Rajapaske Vinodh; Herman Eugene H; Arekani Ali M; Ross Sally; Johann Donald; Knapton Alan; Zhang J; Hitt Ben A; Conrads Thomas P; Veenstra Timothy D; Liotta Lance A; Sistare Frank D
Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection.
Toxicologic pathology 2004;32 Suppl 1():122-30.
-
2004: Petricoin Emanuel; Wulfkuhle Julia; Espina Virginia; Liotta Lance A
Clinical proteomics: revolutionizing disease detection and patient tailoring therapy.
Journal of proteome research 2004;3(2):209-17.
-
2004: Berman David M; Shih Ie-Ming; Burke Lorri-Anne; Veenstra Timothy D; Zhao Yingming; Conrads Thomas P; Kwon Sung Won; Hoang Van; Yu Li-Rong; Zhou Ming; Kurman Robert J; Petricoin Emanuel F; Liotta Lance A
Profiling the activity of G proteins in patient-derived tissues by rapid affinity-capture of signal transduction proteins (GRASP).
Proteomics 2004;4(3):812-8.
-
2004: Alexe Gabriela; Alexe Sorin; Liotta Lance A; Petricoin Emanuel; Reiss Michael; Hammer Peter L
Ovarian cancer detection by logical analysis of proteomic data.
Proteomics 2004;4(3):766-83.
-
2004: Leak Lee V; Liotta Lance A; Krutzsch Henry; Jones Michael; Fusaro Vincent A; Ross Sally J; Zhao Yingming; Petricoin Emanuel F;
Proteomic analysis of lymph.
Proteomics 2004;4(3):753-65.
-
2004: Feldman Andrew L; Espina Virginia; Petricoin Emanuel F; Liotta Lance A; Rosenblatt Kevin P
Use of proteomic patterns to screen for gastrointestinal malignancies.
Surgery 2004;135(3):243-7.
-
2004: Petricoin Emanuel F; Liotta Lance A
SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.
Current opinion in biotechnology 2004;15(1):24-30.
-
2004: Petricoin Emanuel F; Liotta Lance A
Proteomic approaches in cancer risk and response assessment.
Trends in molecular medicine 2004;10(2):59-64.
-
2004: Krieg Rene C; Liotta Lance A; Petricoin Emanuel F; Herrmann Paul C
Trapping radioactive carbon dioxide during cellular metabolic assays under standard culture conditions: description of a unique gas-capturing device.
Journal of biochemical and biophysical methods 2004;58(2):119-24.
-
2004: Geho David H; Petricoin Emanuel F; Liotta Lance A
Blasting into the microworld of tissue proteomics: a new window on cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):825-7.
-
2004: Zha Hongbin; Raffeld Mark; Charboneau Lu; Pittaluga Stefania; Kwak Larry W; Petricoin Emanuel; Liotta Lance A; Jaffe Elaine S
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.
Laboratory investigation; a journal of technical methods and pathology 2004;84(2):235-44.
-
2004: Carr Kristen M; Rosenblatt Kevin; Petricoin Emanuel F; Liotta Lance A
Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy.
Human genomics 2004;1(2):134-40.
-
2004: Espina Virginia; Dettloff Kristine A; Cowherd Stacy; Petricoin Emanuel F; Liotta Lance A
Use of proteomic analysis to monitor responses to biological therapies.
Expert opinion on biological therapy 2004;4(1):83-93.
-
2004: Woodhouse Elisa C; Liotta Lance A
Drosophila invasive tumors: a model for understanding metastasis.
Cell cycle (Georgetown, Tex.) 2004;3(1):38-40.
-
2004: Liotta Lance A
Tumor invasion and metastasis: getting more basic to come closer to the patient. An interview with Lance A. Liotta.
The International journal of developmental biology 2004;48(5-6):559-62.
-
2004: Rosenblatt Kevin P; Bryant-Greenwood Peter; Killian J Keith; Mehta Arpita; Geho David; Espina Virginia; Petricoin Emanuel F; Liotta Lance A
Serum proteomics in cancer diagnosis and management.
Annual review of medicine 2004;55():97-112.
-
2004: Petricoin Emanuel F; Liotta Lance A
Clinical proteomics: application at the bedside.
Contributions to nephrology 2004;141():93-103.
-
2003: Hingorani Sunil R; Petricoin Emanuel F; Maitra Anirban; Rajapakse Vinodh; King Catrina; Jacobetz Michael A; Ross Sally; Conrads Thomas P; Veenstra Timothy D; Hitt Ben A; Kawaguchi Yoshiya; Johann Don; Liotta Lance A; Crawford Howard C; Putt Mary E; Jacks Tyler; Wright Christopher V E; Hruban Ralph H; Lowy Andrew M; Tuveson David A
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.
Cancer cell 2003;4(6):437-50.
-
2003: Nishizuka Satoshi; Charboneau Lu; Young Lynn; Major Sylvia; Reinhold William C; Waltham Mark; Kouros-Mehr Hosein; Bussey Kimberly J; Lee Jae K; Espina Virginia; Munson Peter J; Petricoin Emanuel; Liotta Lance A; Weinstein John N
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(24):14229-34.
-
2003: Grubb Robert L; Calvert Valerie S; Wulkuhle Julia D; Paweletz Cloud P; Linehan W Marston; Phillips John L; Chuaqui Rodrigo; Valasco Alfredo; Gillespie John; Emmert-Buck Michael; Liotta Lance A; Petricoin Emanuel F
Signal pathway profiling of prostate cancer using reverse phase protein arrays.
Proteomics 2003;3(11):2142-6.
-
2003: Espina Virginia; Mehta Arpita I; Winters Mary E; Calvert Valerie; Wulfkuhle Julia; Petricoin Emanuel F; Liotta Lance A
Protein microarrays: molecular profiling technologies for clinical specimens.
Proteomics 2003;3(11):2091-100.
-
2003: Wulfkuhle Julia D; Aquino Joy A; Calvert Valerie S; Fishman David A; Coukos George; Liotta Lance A; Petricoin Emanuel F
Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays.
Proteomics 2003;3(11):2085-90.
-
2003: Liotta Lance A; Ferrari Mauro; Petricoin Emanuel
Clinical proteomics: written in blood.
Nature 2003;425(6961):905.
-
2003: Woodhouse Elisa C; Fisher Amy; Bandle Russell W; Bryant-Greenwood Bianca; Charboneau Lula; Petricoin Emanuel F; Liotta Lance A
Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(20):11463-8.
-
2003: Clair Timothy; Aoki Junken; Koh Eunjin; Bandle Russell W; Nam Suk Woo; Ptaszynska Malgorzata M; Mills Gordon B; Schiffmann Elliott; Liotta Lance A; Stracke Mary L
Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.
Cancer research 2003;63(17):5446-53.
-
2003: Nishizuka Satoshi; Chen Sing-Tsung; Gwadry Fuad G; Alexander Jes; Major Sylvia M; Scherf Uwe; Reinhold William C; Waltham Mark; Charboneau Lu; Young Lynn; Bussey Kimberly J; Kim Sohyoung; Lababidi Samir; Lee Jae K; Pittaluga Stefania; Scudiero Dominic A; Sausville Edward A; Munson Peter J; Petricoin Emmanuel F; Liotta Lance A; Hewitt Stephen M; Raffeld Mark; Weinstein John N
Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling.
Cancer research 2003;63(17):5243-50.
-
2003: Herrmann Paul C; Gillespie John W; Charboneau Lu; Bichsel Verena E; Paweletz Cloud P; Calvert Valerie S; Kohn Elise C; Emmert-Buck Michael R; Liotta Lance A; Petricoin Emanuel F
Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.
Proteomics 2003;3(9):1801-10.
-
2003: Liotta Lance A; Petricoin Emanuel F
The promise of proteomics.
Clinical advances in hematology & oncology : H&O 2003;1(8):460-2.
-
2003: Krieg Rene C; Paweletz Cloud P; Liotta Lance A; Petricoin Emanuel F
Dilution of protein gel stain results in retention of staining capacity.
BioTechniques 2003;35(2):376-8.
-
2003: Petricoin Emanuel; Liotta Lance A
Counterpoint: The vision for a new diagnostic paradigm.
Clinical chemistry 2003;49(8):1276-8.
-
2003: Conrads Thomas P; Zhou Ming; Petricoin Emmanuel F; Liotta Lance; Veenstra Timothy D
Cancer diagnosis using proteomic patterns.
Expert review of molecular diagnostics 2003;3(4):411-20.
-
2003: Geho David H; Smith William I; Liotta Lance A; Roberts David D
Fibronectin-based masking molecule blocks platelet adhesion.
Bioconjugate chemistry 2003;14(4):703-6.
-
2003: Petricoin Emanuel F; Liotta Lance A
Clinical applications of proteomics.
The Journal of nutrition 2003;133(7 Suppl):2476S-2484S.
-
2003: Bottaro Donald P; Liotta Lance A
Cancer: Out of air is not out of action.
Nature 2003;423(6940):593-5.
-
2003: Barrett J Carl; Bennett L Michelle; Fleming Laura Kay; Linehan W Marston; Liotta Lance A; Rosenberg Steven A; Petricoin Emanuel F; Staudt Louis M; Thompson Tracy E; Yang James C
Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer research.
Clinical advances in hematology & oncology : H&O 2003;1(5):302-6.
-
2003: Koh Eunjin; Clair Timothy; Woodhouse Elisa C; Schiffmann Elliott; Liotta Lance; Stracke Mary
Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities.
Cancer research 2003;63(9):2042-5.
-
2003: Liotta Lance A; Espina Virginia; Mehta Arpita I; Calvert Valerie; Rosenblatt Kevin; Geho David; Munson Peter J; Young Lynn; Wulfkuhle Julia; Petricoin Emanuel F
Protein microarrays: meeting analytical challenges for clinical applications.
Cancer cell 2003;3(4):317-25.
-
2003: Wulfkuhle Julia D; Liotta Lance A; Petricoin Emanuel F
Proteomic applications for the early detection of cancer.
Nature reviews. Cancer 2003;3(4):267-75.
-
2003: Petricoin Emanuel F; Liotta Lance A
Mass spectrometry-based diagnostics: the upcoming revolution in disease detection.
Clinical chemistry 2003;49(4):533-4.
-
2003: Liotta Lance A; Petricoin Emanuel F; Ardekani Ali M; Hitt Ben A; Levine Peter J; Fusaro Vincent A; Steinberg Seth M; Mills Gordon B; Simone Charles; Fishman David A; Kohn Elise C
General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.
Gynecologic oncology 2003;88(1 Pt 2):S25-8; discussion S37-42.
-
2003: Jones Monica Brown; Michener Chad M; Blanchette James O; Kuznetsov Vladimir A; Raffeld Mark; Serrero Ginette; Emmert-Buck Michael R; Petricoin Emanuel F; Krizman David B; Liotta Lance A; Kohn Elise C
The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):44-51.
-
2003: Liotta Lance A; Kohn Elise C
Cancer's deadly signature.
Nature genetics 2003;33(1):10-1.
-
2003: Johann Donald J; McGuigan Michael D; Tomov Stanimire; Fusaro Vincent A; Ross Sally; Conrads Thomas P; Veenstra Timothy D; Fishman David A; Whiteley Gordon R; Petricoin Emanuel F; Liotta Lance A
Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patients.
Disease markers 2003;19(4-5):197-207.
-
2003: Mehta Arpita I; Ross Sally; Lowenthal Mark S; Fusaro Vincent; Fishman David A; Petricoin Emanuel F; Liotta Lance A
Biomarker amplification by serum carrier protein binding.
Disease markers 2003;19(1):1-10.
-
2003: Braziel Rita M; Shipp Margaret A; Feldman Andrew L; Espina Virginia; Winters Mary; Jaffe Elaine S; Petricoin Emanuel F; Liotta Lance A
Molecular diagnostics.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2003;():279-93.
-
2003: Wulfkuhle Julia D; Paweletz Cloud P; Steeg Patricia S; Petricoin Emanuel F; Liotta Lance
Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.
Advances in experimental medicine and biology 2003;532():59-68.
-
2002: Petricoin Emanuel F; Liotta Lance A
Proteomic analysis at the bedside: early detection of cancer.
Trends in biotechnology 2002;20(12 Suppl):S30-4.
-
2002: Leak Lee V; Petricoin Emanuel F; Jones Michael; Paweletz Cloud P; Ardekani Ali M; Fusaro Vincent A; Ross Sally; Liotta Lance A
Proteomic technologies to study diseases of the lymphatic vascular system.
Annals of the New York Academy of Sciences 2002;979():211-28; discussion 229-34.
-
2002: Fetsch Patricia A; Simone Nicole L; Bryant-Greenwood Peter K; Marincola Francesco M; Filie Armando C; Petricoin Emmanuel F; Liotta Lance A; Abati Andrea
Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry: potential for diagnostic applications.
American journal of clinical pathology 2002;118(6):870-6.
-
2002: Miyaji Takehiko; Hewitt Stephen M; Liotta Lance A; Star Robert A
Frozen protein arrays: a new method for arraying and detecting recombinant and native tissue proteins.
Proteomics 2002;2(11):1489-93.
-
2002: Charboneau Lu; Tory Heather; Chen Tina; Winters Mary; Petricoin Emanuel F; Liotta Lance A; Paweletz Cloud P
Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays.
Briefings in functional genomics & proteomics 2002;1(3):305-15.
-
2002: Petricoin Emanuel E; Paweletz Cloud P; Liotta Lance A
Clinical applications of proteomics: proteomic pattern diagnostics.
Journal of mammary gland biology and neoplasia 2002;7(4):433-40.
-
2002: Petricoin Emanuel F; Ornstein David K; Paweletz Cloud P; Ardekani Ali; Hackett Paul S; Hitt Ben A; Velassco Alfredo; Trucco Christian; Wiegand Laura; Wood Kamillah; Simone Charles B; Levine Peter J; Linehan W Marston; Emmert-Buck Michael R; Steinberg Seth M; Kohn Elise C; Liotta Lance A
Serum proteomic patterns for detection of prostate cancer.
Journal of the National Cancer Institute 2002;94(20):1576-8.
-
2002: Petricoin Emanuel F; Zoon Kathryn C; Kohn Elise C; Barrett J Carl; Liotta Lance A
Clinical proteomics: translating benchside promise into bedside reality.
Nature reviews. Drug discovery 2002;1(9):683-95.
-
2002: Krieg Rene C; Paweletz Cloud P; Liotta Lance A; Petricoin Emanuel F
Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
Technology in cancer research & treatment 2002;1(4):263-72.
-
2002: Liotta Lance A; Kohn Elise C
Stromal therapy: the next step in ovarian cancer treatment.
Journal of the National Cancer Institute 2002;94(15):1113-4.
-
2002: Ardekani Ali M; Liotta Lance A; Petricoin Emanuel F
Clinical potential of proteomics in the diagnosis of ovarian cancer.
Expert review of molecular diagnostics 2002;2(4):312-20.
-
2002: Miura Koh; Bowman Elise D; Simon Richard; Peng Amy C; Robles Ana I; Jones Raymond T; Katagiri Toyomasa; He Ping; Mizukami Hiroki; Charboneau Lu; Kikuchi Takefumi; Liotta Lance A; Nakamura Yusuke; Harris Curtis C
Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles.
Cancer research 2002;62(11):3244-50.
-
2002: Zhou Ge; Li Hongmei; DeCamp Dianne; Chen She; Shu Hongjun; Gong Yi; Flaig Michael; Gillespie John W; Hu Nan; Taylor Philip R; Emmert-Buck Michael R; Liotta Lance A; Petricoin Emanuel F; Zhao Yingming
2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers.
Molecular & cellular proteomics : MCP 2002;1(2):117-24.
-
2002: Petricoin Emanuel F; Ardekani Ali M; Hitt Ben A; Levine Peter J; Fusaro Vincent A; Steinberg Seth M; Mills Gordon B; Simone Charles; Fishman David A; Kohn Elise C; Liotta Lance A
Use of proteomic patterns in serum to identify ovarian cancer.
Lancet 2002;359(9306):572-7.
-
2002: Jones Monica Brown; Krutzsch Henry; Shu Hungjun; Zhao Yingming; Liotta Lance A; Kohn Elise C; Petricoin Emmanuel F
Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
Proteomics 2002;2(1):76-84.
-
2002: Michener Chad M; Ardekani Ali M; Petricoin Emmanuel F; Liotta Lance A; Kohn Elise C
Genomics and proteomics: application of novel technology to early detection and prevention of cancer.
Cancer detection and prevention 2002;26(4):249-55.
-
2001: Paweletz C P; Charboneau L; Liotta L A
Overview of metastasis assays.
Current protocols in cell biology / editorial board, Juan S. Bonifacino ... [et al.] 2001;Chapter 19():Unit 19.1.
-
2001: Knezevic V; Leethanakul C; Bichsel V E; Worth J M; Prabhu V V; Gutkind J S; Liotta L A; Munson P J; Petricoin E F; Krizman D B
Proteomic profiling of the cancer microenvironment by antibody arrays.
Proteomics 2001;1(10):1271-8.
-
2001: Nam S W; Clair T; Kim Y S; McMarlin A; Schiffmann E; Liotta L A; Stracke M L
Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.
Cancer research 2001;61(18):6938-44.
-
2001: Ward Y; Wang W; Woodhouse E; Linnoila I; Liotta L; Kelly K
Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways.
Molecular and cellular biology 2001;21(17):5958-69.
-
2001: Nicholson S A; Okby N T; Khan M A; Welsh J A; McMenamin M G; Travis W D; Jett J R; Tazelaar H D; Trastek V; Pairolero P C; Corn P G; Herman J G; Liotta L A; Caporaso N E; Harris C C
Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.
Cancer research 2001;61(14):5636-43.
-
2001: Kohn E C; Reed E; Sarosy G A; Minasian L; Bauer K S; Bostick-Bruton F; Kulpa V; Fuse E; Tompkins A; Noone M; Goldspiel B; Pluda J; Figg W D; Liotta L A
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1600-9.
-
2001: Charboneau L; Paweletz C P; Liotta L A
Laser capture microdissection.
Current protocols in cell biology / editorial board, Juan S. Bonifacino ... [et al.] 2001;Chapter 2():Unit 2.5.
-
2001: Paweletz C P; Charboneau L; Liotta L A
Micro RT-PCR.
Current protocols in cell biology / editorial board, Juan S. Bonifacino ... [et al.] 2001;Appendix 3():Appendix 3G.
-
2001: Liotta L A; Kohn E C
The microenvironment of the tumour-host interface.
Nature 2001;411(6835):375-9.
-
2001: Paweletz C P; Charboneau L; Bichsel V E; Simone N L; Chen T; Gillespie J W; Emmert-Buck M R; Roth M J; Petricoin III E F; Liotta L A
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.
Oncogene 2001;20(16):1981-9.
-
2001: Paweletz C P; Liotta L A; Petricoin E F
New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics.
Urology 2001;57(4 Suppl 1):160-3.
-
2001: Bichsel V E; Liotta L A; Petricoin E F
Cancer proteomics: from biomarker discovery to signal pathway profiling.
Cancer journal (Sudbury, Mass.) 2001;7(1):69-78.
-
2001: Gillespie J W; Ahram M; Best C J; Swalwell J I; Krizman D B; Petricoin E F; Liotta L A; Emmert-Buck M R
The role of tissue microdissection in cancer research.
Cancer journal (Sudbury, Mass.) 2001;7(1):32-9.
-
2001: Paweletz C P; Trock B; Pennanen M; Tsangaris T; Magnant C; Liotta L A; Petricoin E F
Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer.
Disease markers 2001;17(4):301-7.
-
2001: Herrmann P C; Liotta L A; Petricoin E F
Cancer proteomics: the state of the art.
Disease markers 2001;17(2):49-57.
-
2000: Simone N L; Paweletz C P; Charboneau L; Petricoin E F; Liotta L A
Laser capture microdissection: beyond functional genomics to proteomics.
Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology 2000;5(4):301-7.
-
2000: Marrogi A J; Travis W D; Welsh J A; Khan M A; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso N E; Liotta L A; Harris C C
Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4739-44.
-
2000: Paweletz C P; Ornstein D K; Roth M J; Bichsel V E; Gillespie J W; Calvert V S; Vocke C D; Hewitt S M; Duray P H; Herring J; Wang Q H; Hu N; Linehan W M; Taylor P R; Liotta L A; Emmert-Buck M R; Petricoin E F
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma.
Cancer research 2000;60(22):6293-7.
-
2000: Doong H; Price J; Kim Y S; Gasbarre C; Probst J; Liotta L A; Blanchette J; Rizzo K; Kohn E
CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70.
Oncogene 2000;19(38):4385-95.
-
2000: Murakami H; Liotta L; Star R A
IF-LCM: laser capture microdissection of immunofluorescently defined cells for mRNA analysis rapid communication.
Kidney international 2000;58(3):1346-53.
-
2000: Nam S W; Clair T; Schiffmann E; Liotta L A; Stracke M L
A sensitive screening assay for secreted motility-stimulating factors.
Cell motility and the cytoskeleton 2000;46(4):279-84.
-
2000: Leethanakul C; Patel V; Gillespie J; Pallente M; Ensley J F; Koontongkaew S; Liotta L A; Emmert-Buck M; Gutkind J S
Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays.
Oncogene 2000;19(28):3220-4.
-
2000: Caffrey M; Braddock D T; Louis J M; Abu-Asab M A; Kingma D; Liotta L; Tsokos M; Tresser N; Pannell L K; Watts N; Steven A C; Simon M N; Stahl S J; Wingfield P T; Clore G M
Biophysical characterization of gp41 aggregates suggests a model for the molecular mechanism of HIV-associated neurological damage and dementia.
The Journal of biological chemistry 2000;275(26):19877-82.
-
2000: Carlisle A J; Prabhu V V; Elkahloun A; Hudson J; Trent J M; Linehan W M; Williams E D; Emmert-Buck M R; Liotta L A; Munson P J; Krizman D B
Development of a prostate cDNA microarray and statistical gene expression analysis package.
Molecular carcinogenesis 2000;28(1):12-22.
-
2000: Galateau-Salle F B; Luna R E; Horiba K; Sheppard M N; Hayashi T; Fleming M V; Colby T V; Bennett W; Harris C C; Stetler-Stevenson W G; Liotta L; Ferrans V J; Travis W D
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions.
Human pathology 2000;31(3):296-305.
-
2000: Simone N L; Remaley A T; Charboneau L; Petricoin E F; Glickman J W; Emmert-Buck M R; Fleisher T A; Liotta L A
Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection.
The American journal of pathology 2000;156(2):445-52.
-
2000: Nam S W; Clair T; Campo C K; Lee H Y; Liotta L A; Stracke M L
Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells.
Oncogene 2000;19(2):241-7.
-
2000: Bichsel V E; Petricion E F; Liotta L A
The state of the art microdissection and its downstream applications.
Journal of molecular medicine (Berlin, Germany) 2000;78(7):B20.
-
2000: Best C J; Gillespie J W; Englert C R; Swalwell J I; Pfeifer J; Krizman D B; Petricoin E F; Liotta L A; Emmert-Buck M R
New approaches to molecular profiling of tissue samples.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 2000;20(1):1-6.
-
1999: Pack S D; Zbar B; Pak E; Ault D O; Humphrey J S; Pham T; Hurley K; Weil R J; Park W S; Kuzmin I; Stolle C; Glenn G; Liotta L A; Lerman M I; Klausner R D; Linehan W M; Zhuang Z
Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.
Cancer research 1999;59(21):5560-4.
-
1999: Strup S E; Pozzatti R O; Florence C D; Emmert-Buck M R; Duray P H; Liotta L A; Bostwick D G; Linehan W M; Vocke C D
Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas.
The Journal of urology 1999;162(2):590-4.
-
1999: Marx S J; Agarwal S K; Heppner C; Kim Y S; Kester M B; Goldsmith P K; Skarulis M C; Spiegel A M; Burns A L; Debelenko L V; Zhuang Z; Lubensky I A; Liotta L A; Emmert-Buck M R; Guru S C; Manickam P; Crabtree J S; Collins F S; Chandrasekharappa S C
The gene for multiple endocrine neoplasia type 1: recent findings.
Bone 1999;25(1):119-22.
-
1999: Pack S D; Karkera J D; Zhuang Z; Pak E D; Balan K V; Hwu P; Park W S; Pham T; Ault D O; Glaser M; Liotta L; Detera-Wadleigh S D; Wadleigh R G
Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations.
Genes, chromosomes & cancer 1999;25(2):160-8.
-
1999: Fend F; Emmert-Buck M R; Chuaqui R; Cole K; Lee J; Liotta L A; Raffeld M
Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis.
The American journal of pathology 1999;154(1):61-6.
-
1999: Marx S J; Agarwal S K; Kester M B; Heppner C; Kim Y S; Skarulis M C; James L A; Goldsmith P K; Saggar S K; Park S Y; Spiegel A M; Burns A L; Debelenko L V; Zhuang Z; Lubensky I A; Liotta L A; Emmert-Buck M R; Guru S C; Manickam P; Crabtree J; Erdos M R; Collins F S; Chandrasekharappa S C
Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Recent progress in hormone research 1999;54():397-438; discussion 438-9.
-
1998: Przygodzki R M; Bennett W P; Guinee D G; Khan M A; Freedman A; Shields P G; Travis W D; Jett J R; Tazelaar H; Pairolero P; Trastek V; Liotta L A; Harris C C; Caporaso N E
p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.
Pharmacogenetics 1998;8(6):503-11.
-
1998: Peterson L A; Brown M R; Carlisle A J; Kohn E C; Liotta L A; Emmert-Buck M R; Krizman D B
An improved method for construction of directionally cloned cDNA libraries from microdissected cells.
Cancer research 1998;58(23):5326-8.
-
1998: Marx S; Spiegel A M; Skarulis M C; Doppman J L; Collins F S; Liotta L A
Multiple endocrine neoplasia type 1: clinical and genetic topics.
Annals of internal medicine 1998;129(6):484-94.
-
1998: Mulvaney P T; Stracke M L; Nam S W; Woodhouse E; O'Keefe M; Clair T; Liotta L A; Khaddurah-Daouk R; Schiffmann E
Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase.
International journal of cancer. Journal international du cancer 1998;78(1):46-52.
-
1998: Cole K A; Chuaqui R F; Katz K; Pack S; Zhuang Z; Cole C E; Lyne J C; Linehan W M; Liotta L A; Emmert-Buck M R
cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer.
Genomics 1998;51(2):282-7.
-
1998: Simone N L; Bonner R F; Gillespie J W; Emmert-Buck M R; Liotta L A
Laser-capture microdissection: opening the microscopic frontier to molecular analysis.
Trends in genetics : TIG 1998;14(7):272-6.
-
1998: Pappalardo P A; Bonner R; Krizman D B; Emmert-Buck M R; Liotta L A
Microdissection, microchip arrays, and molecular analysis of tumor cells (primary and metastases).
Seminars in radiation oncology 1998;8(3):217-23.
-
1998: Marx S J; Agarwal S K; Kester M B; Heppner C; Kim Y S; Emmert-Buck M R; Debelenko L V; Lubensky I A; Zhuang Z; Guru S C; Manickam P; Olufemi S E; Skarulis M C; Doppman J L; Alexander R H; Liotta L A; Collins F S; Chandrasekharappa S C; Spiegel A M; Burns A L
Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1).
Journal of internal medicine 1998;243(6):447-53.
-
1998: Burke L; Khan M A; Freedman A N; Gemma A; Rusin M; Guinee D G; Bennett W P; Caporaso N E; Fleming M V; Travis W D; Colby T V; Trastek V; Pairolero P C; Tazelaar H D; Midthun D E; Liotta L A; Harris C C
Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Cancer research 1998;58(12):2533-6.
-
1998: Bennett W P; el-Deiry W S; Rush W L; Guinee D G; Freedman A N; Caporaso N E; Welsh J A; Jones R T; Borkowski A; Travis W D; Fleming M V; Trastek V; Pairolero P C; Tazelaar H D; Midthun D; Jett J R; Liotta L A; Harris C C
p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(6):1499-506.
-
1998: Woodhouse E C; Amanatullah D F; Schetz J A; Liotta L A; Stracke M L; Clair T
Adenosine receptor mediates motility in human melanoma cells.
Biochemical and biophysical research communications 1998;246(3):888-94.
-
1998: Vortmeyer A O; Merino M J; Böni R; Liotta L A; Cavazzana A; Zhuang Z
Genetic changes associated with primary Merkel cell carcinoma.
American journal of clinical pathology 1998;109(5):565-70.
-
1998: Emmert-Buck M R; Debelenko L V; Agarwal S; Kester M B; Manickam P; Zhuang Z; Guru S C; Olufemi S E; Burns A L; Chandrasekharappa S C; Lubensky I A; Liotta L A; Skarulis M C; Spiegel A M; Marx S J; Collins F S
11q13 allelotype analysis in 27 northern American MEN1 kindreds identifies two distinct founder chromosomes.
Molecular genetics and metabolism 1998;63(2):151-5.
-
1998: Park W S; Vortmeyer A O; Pack S; Duray P H; Böni R; Guerami A A; Emmert-Buck M R; Liotta L A; Zhuang Z
Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus.
Human pathology 1998;29(2):127-30.
-
1998: Fleming M V; Guinee D G; Chu W S; Freedman A N; Caporaso N E; Bennett W P; Colby T V; Tazelaar H; Abbondanzo S L; Jett J; Pairolero P; Trastek V; Liotta L A; Harris C C; Travis W D
Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients.
Human pathology 1998;29(1):60-4.
-
1998: Agarwal S K; Debelenko L V; Kester M B; Guru S C; Manickam P; Olufemi S E; Skarulis M C; Heppner C; Crabtree J S; Lubensky I A; Zhuang Z; Kim Y S; Chandrasekharappa S C; Collins F S; Liotta L A; Spiegel A M; Burns A L; Emmert-Buck M R; Marx S J
Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families.
Human mutation 1998;12(2):75-82.
-
1997: Zhuang Z; Ezzat S Z; Vortmeyer A O; Weil R; Oldfield E H; Park W S; Pack S; Huang S; Agarwal S K; Guru S C; Manickam P; Debelenko L V; Kester M B; Olufemi S E; Heppner C; Crabtree J S; Burns A L; Spiegel A M; Marx S J; Chandrasekharappa S C; Collins F S; Emmert-Buck M R; Liotta L A; Asa S L; Lubensky I A
Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Cancer research 1997;57(24):5446-51.
-
1997: Debelenko L V; Brambilla E; Agarwal S K; Swalwell J I; Kester M B; Lubensky I A; Zhuang Z; Guru S C; Manickam P; Olufemi S E; Chandrasekharappa S C; Crabtree J S; Kim Y S; Heppner C; Burns A L; Spiegel A M; Marx S J; Liotta L A; Collins F S; Travis W D; Emmert-Buck M R
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung.
Human molecular genetics 1997;6(13):2285-90.
-
1997: Bonner R F; Emmert-Buck M; Cole K; Pohida T; Chuaqui R; Goldstein S; Liotta L A
Laser capture microdissection: molecular analysis of tissue.
Science (New York, N.Y.) 1997;278(5342):1481,1483.
-
1997: Manickam P; Guru S C; Debelenko L V; Agarwal S K; Olufemi S E; Weisemann J M; Boguski M S; Crabtree J S; Wang Y; Roe B A; Lubensky I A; Zhuang Z; Kester M B; Burns A L; Spiegel A M; Marx S J; Liotta L A; Emmert-Buck M R; Collins F S; Chandrasekharappa S C
Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region.
Human genetics 1997;101(1):102-8.
-
1997: Yasui H; Butscher W; Cohen M; Spriggs N; Wersto R; Kohn E C; Liotta L; Gardner K
Selective inhibition of mitogen-induced transactivation of the HIV long terminal repeat by carboxyamidotriazole. Calcium influx blockade represses HIV-1 transcriptional activation.
The Journal of biological chemistry 1997;272(45):28762-70.
-
1997: Woodhouse E C; Chuaqui R F; Liotta L A
General mechanisms of metastasis.
Cancer 1997;80(8 Suppl):1529-37.
-
1997: Dean-Clower E; Vortmeyer A O; Bonner R F; Emmert-Buck M; Zhuang Z; Liotta L A
Microdissection-based genetic discovery and analysis applied to cancer progression.
The cancer journal from Scientific American 1997;3(5):259-65.
-
1997: Hayashi T; Fleming M V; Stetler-Stevenson W G; Liotta L A; Moss J; Ferrans V J; Travis W D
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).
Human pathology 1997;28(9):1071-8.
-
1997: Hayashi T; Rush W L; Travis W D; Liotta L A; Stetler-Stevenson W G; Ferrans V J
Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis.
Archives of pathology & laboratory medicine 1997;121(9):930-7.
-
1997: Debelenko L V; Emmert-Buck M R; Zhuang Z; Epshteyn E; Moskaluk C A; Jensen R T; Liotta L A; Lubensky I A
The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
Gastroenterology 1997;113(3):773-81.
-
1997: Chuaqui R F; Englert C R; Strup S E; Vocke C D; Zhuang Z; Duray P H; Bostwick D G; Linehan W M; Liotta L A; Emmert-Buck M R
Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma.
Urology 1997;50(2):302-7.
-
1997: Heppner C; Kester M B; Agarwal S K; Debelenko L V; Emmert-Buck M R; Guru S C; Manickam P; Olufemi S E; Skarulis M C; Doppman J L; Alexander R H; Kim Y S; Saggar S K; Lubensky I A; Zhuang Z; Liotta L A; Chandrasekharappa S C; Collins F S; Spiegel A M; Burns A L; Marx S J
Somatic mutation of the MEN1 gene in parathyroid tumours.
Nature genetics 1997;16(4):375-8.
-
1997: Guru S C; Agarwal S K; Manickam P; Olufemi S E; Crabtree J S; Weisemann J M; Kester M B; Kim Y S; Wang Y; Emmert-Buck M R; Liotta L A; Spiegel A M; Boguski M S; Roe B A; Collins F S; Marx S J; Burns L; Chandrasekharappa S C
A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus.
Genome research 1997;7(7):725-35.
-
1997: Clair T; Krutzsch H C; Liotta L A; Stracke M L
Nucleotide binding to autotaxin: crosslinking of bound substrate followed by lysC digestion identifies two labeled peptides.
Biochemical and biophysical research communications 1997;236(2):449-54.
-
1997: Agarwal S K; Kester M B; Debelenko L V; Heppner C; Emmert-Buck M R; Skarulis M C; Doppman J L; Kim Y S; Lubensky I A; Zhuang Z; Green J S; Guru S C; Manickam P; Olufemi S E; Liotta L A; Chandrasekharappa S C; Collins F S; Spiegel A M; Burns A L; Marx S J
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.
Human molecular genetics 1997;6(7):1169-75.
-
1997: Debelenko L V; Zhuang Z; Emmert-Buck M R; Chandrasekharappa S C; Manickam P; Guru S C; Marx S J; Skarulis M C; Spiegel A M; Collins F S; Jensen R T; Liotta L A; Lubensky I A
Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
Cancer research 1997;57(11):2238-43.
-
1997: Beckner M E; Krutzsch H C; Tsokos M; Moul D E; Liotta L A
The aggregated form of an AAMP derived peptide behaves as a heparin sensitive cell binding agent.
Biotechnology and bioengineering 1997;54(4):365-72.
-
1997: Kohn E C; Figg W D; Sarosy G A; Bauer K S; Davis P A; Soltis M J; Thompkins A; Liotta L A; Reed E
Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1985-93.
-
1997: Emmert-Buck M R; Lubensky I A; Dong Q; Manickam P; Guru S C; Kester M B; Olufemi S E; Agarwal S; Burns A L; Spiegel A M; Collins F S; Marx S J; Zhuang Z; Liotta L A; Chandrasekharappa S C; Debelenko L V
Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.
Cancer research 1997;57(10):1855-8.
-
1997: Dong Q; Debelenko L V; Chandrasekharappa S C; Emmert-Buck M R; Zhuang Z; Guru S C; Manickam P; Skarulis M; Lubensky I A; Liotta L A; Collins F S; Marx S J; Spiegel A M
Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1.
The Journal of clinical endocrinology and metabolism 1997;82(5):1416-20.
-
1997: Chandrasekharappa S C; Guru S C; Manickam P; Olufemi S E; Collins F S; Emmert-Buck M R; Debelenko L V; Zhuang Z; Lubensky I A; Liotta L A; Crabtree J S; Wang Y; Roe B A; Weisemann J; Boguski M S; Agarwal S K; Kester M B; Kim Y S; Heppner C; Dong Q; Spiegel A M; Burns A L; Marx S J
Positional cloning of the gene for multiple endocrine neoplasia-type 1.
Science (New York, N.Y.) 1997;276(5311):404-7.
-
1997: Emmert-Buck M R; Chuaqui R; Zhuang Z; Nogales F; Liotta L A; Merino M J
Molecular analysis of synchronous uterine and ovarian endometrioid tumors.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1997;16(2):143-8.
-
1997: Debelenko L V; Emmert-Buck M R; Manickam P; Kester M; Guru S C; DiFranco E M; Olufemi S E; Agarwal S; Lubensky I A; Zhuang Z; Burns A L; Spiegel A M; Liotta L A; Collins F S; Marx S J; Chandrasekharappa S C
Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene.
Cancer research 1997;57(6):1039-42.
-
1997: Chuaqui R F; Zhuang Z; Emmert-Buck M R; Liotta L A; Merino M J
Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
The American journal of pathology 1997;150(1):297-303.
-
1997: Clair T; Lee H Y; Liotta L A; Stracke M L
Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities.
The Journal of biological chemistry 1997;272(2):996-1001.
-
1997: Stracke M L; Clair T; Liotta L A
Autotaxin, tumor motility-stimulating exophosphodiesterase.
Advances in enzyme regulation 1997;37():135-44.
-
1996: Krizman D B; Chuaqui R F; Meltzer P S; Trent J M; Duray P H; Linehan W M; Liotta L A; Emmert-Buck M R
Construction of a representative cDNA library from prostatic intraepithelial neoplasia.
Cancer research 1996;56(23):5380-3.
-
1996: Harty L C; Guinee D G; Travis W D; Bennett W P; Jett J; Colby T V; Tazelaar H; Trastek V; Pairolero P; Liotta L A; Harris C C; Caporaso N E
p53 mutations and occupational exposures in a surgical series of lung cancers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(12):997-1003.
-
1996: Lubensky I A; Debelenko L V; Zhuang Z; Emmert-Buck M R; Dong Q; Chandrasekharappa S; Guru S C; Manickam P; Olufemi S E; Marx S J; Spiegel A M; Collins F S; Liotta L A
Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients.
Cancer research 1996;56(22):5272-8.
-
1996: Emmert-Buck M R; Bonner R F; Smith P D; Chuaqui R F; Zhuang Z; Goldstein S R; Weiss R A; Liotta L A
Laser capture microdissection.
Science (New York, N.Y.) 1996;274(5289):998-1001.
-
1996: Hayashi T; Stetler-Stevenson W G; Fleming M V; Fishback N; Koss M N; Liotta L A; Ferrans V J; Travis W D
Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.
The American journal of pathology 1996;149(4):1241-56.
-
1996: Lee H Y; Clair T; Mulvaney P T; Woodhouse E C; Aznavoorian S; Liotta L A; Stracke M L
Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin.
The Journal of biological chemistry 1996;271(40):24408-12.
-
1996: Woodhouse E; Emmert-Buck M; Zhuang Z; Liotta L
The revolution in cancer molecular diagnostics.
The cancer journal from Scientific American 1996;2(4):197-9.
-
1996: Beckner M E; Liotta L A
AAMP, a conserved protein with immunoglobulin and WD40 domains, regulates endothelial tube formation in vitro.
Laboratory investigation; a journal of technical methods and pathology 1996;75(1):97-107.
-
1996: Beckner M E; Krutzsch H C; Klipstein S; Williams S T; Maguire J E; Doval M; Liotta L A
AAMP, a newly identified protein, shares a common epitope with alpha-actinin and a fast skeletal muscle fiber protein.
Experimental cell research 1996;225(2):306-14.
-
1996: Vocke C D; Pozzatti R O; Bostwick D G; Florence C D; Jennings S B; Strup S E; Duray P H; Liotta L A; Emmert-Buck M R; Linehan W M
Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
Cancer research 1996;56(10):2411-6.
-
1996: Zhuang Z; Vortmeyer A O; Mark E J; Odze R; Emmert-Buck M R; Merino M J; Moon H; Liotta L A; Duray P H
Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma.
Cancer research 1996;56(9):1961-4.
-
1996: Alessandro R; Masiero L; Liotta L A; Kohn E C
The role of calcium in the regulation of invasion and angiogenesis.
In vivo (Athens, Greece) 1996;10(2):153-60.
-
1996: Aznavoorian S; Stracke M L; Parsons J; McClanahan J; Liotta L A
Integrin alphavbeta3 mediates chemotactic and haptotactic motility in human melanoma cells through different signaling pathways.
The Journal of biological chemistry 1996;271(6):3247-54.
-
1996: Zhuang Z; Emmert-Buck M R; Roth M J; Gnarra J; Linehan W M; Liotta L A; Lubensky I A
von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens.
Human pathology 1996;27(2):152-6.
-
1996: Kohn E C; Reed E; Sarosy G; Christian M; Link C J; Cole K; Figg W D; Davis P A; Jacob J; Goldspiel B; Liotta L A
Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.
Cancer research 1996;56(3):569-73.
-
1996: Lee H Y; Murata J; Clair T; Polymeropoulos M H; Torres R; Manrow R E; Liotta L A; Stracke M L
Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells.
Biochemical and biophysical research communications 1996;218(3):714-9.
-
1995: Liotta L A
Introduction to the U.S.--Italy Workshop on the Molecular Genetics of Cancer.
Cancer 1995;76(10):1868.
-
1995: Sanz-Ortega J; Chuaqui R; Zhuang Z; Sobel M E; Sanz-Esponera J; Liotta L A; Emmert-Buck M R; Merino M J
Loss of heterozygosity on chromosome 11q13 in microdissected human male breast carcinomas.
Journal of the National Cancer Institute 1995;87(18):1408-10.
-
1995: Stracke M L; Arestad A; Levine M; Krutzsch H C; Liotta L A
Autotaxin is an N-linked glycoprotein but the sugar moieties are not needed for its stimulation of cellular motility.
Melanoma research 1995;5(4):203-9.
-
1995: Emmert-Buck M R; Vocke C D; Pozzatti R O; Duray P H; Jennings S B; Florence C D; Zhuang Z; Bostwick D G; Liotta L A; Linehan W M
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia.
Cancer research 1995;55(14):2959-62.
-
1995: Beckner M E; Krutzsch H C; Stracke M L; Williams S T; Gallardo J A; Liotta L A
Identification of a new immunoglobulin superfamily protein expressed in blood vessels with a heparin-binding consensus sequence.
Cancer research 1995;55(10):2140-9.
-
1995: Kohn E C; Liotta L A
Molecular insights into cancer invasion: strategies for prevention and intervention.
Cancer research 1995;55(9):1856-62.
-
1995: Zhuang Z; Bertheau P; Emmert-Buck M R; Liotta L A; Gnarra J; Linehan W M; Lubensky I A
A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size.
The American journal of pathology 1995;146(3):620-5.
-
1995: Zhuang Z; Merino M J; Chuaqui R; Liotta L A; Emmert-Buck M R
Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
Cancer research 1995;55(3):467-71.
-
1995: Kohn E C; Alessandro R; Spoonster J; Wersto R P; Liotta L A
Angiogenesis: role of calcium-mediated signal transduction.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(5):1307-11.
-
1994: Emmert-Buck M R; Roth M J; Zhuang Z; Campo E; Rozhin J; Sloane B F; Liotta L A; Stetler-Stevenson W G
Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples.
The American journal of pathology 1994;145(6):1285-90.
-
1994: Murata J; Lee H Y; Clair T; Krutzsch H C; Arestad A A; Sobel M E; Liotta L A; Stracke M L
cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases.
The Journal of biological chemistry 1994;269(48):30479-84.
-
1994: Zhuang Z; Roth M J; Emmert-Buck M R; Lubensky I A; Liotta L A; Solomon D
Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction.
Acta cytologica 1994;38(5):671-5.
-
1994: Kohn E C; Jacobs W; Kim Y S; Alessandro R; Stetler-Stevenson W G; Liotta L A
Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A).
The Journal of biological chemistry 1994;269(34):21505-11.
-
1994: Kohn E C; Felder C C; Jacobs W; Holmes K A; Day A; Freer R; Liotta L A
Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI.
Cancer research 1994;54(4):935-42.
-
1994: Stracke M L; Murata J; Aznavoorian S; Liotta L A
The role of the extracellular matrix in tumor cell metastasis.
In vivo (Athens, Greece) 1994;8(1):49-58.
-
1993: Kohn E C; Hollister G H; DiPersio J D; Wahl S; Liotta L A; Schiffmann E
Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration.
International journal of cancer. Journal international du cancer 1993;53(6):968-72.
-
1993: Aznavoorian S; Murphy A N; Stetler-Stevenson W G; Liotta L A
Molecular aspects of tumor cell invasion and metastasis.
Cancer 1993;71(4):1368-83.
-
1993: Stetler-Stevenson W G; Aznavoorian S; Liotta L A
Tumor cell interactions with the extracellular matrix during invasion and metastasis.
Annual review of cell biology 1993;9():541-73.
-
1993: Stracke M; Liotta L A; Schiffmann E
The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility.
Symposia of the Society for Experimental Biology 1993;47():197-214.
-
1992: Campo E; Merino M J; Liotta L; Neumann R; Stetler-Stevenson W
Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue.
Human pathology 1992;23(12):1395-401.
-
1992: Stetler-Stevenson W G; Liotta L A; Seldin M F
Linkage analysis demonstrates that the Timp-2 locus is on mouse chromosome 11.
Genomics 1992;14(3):828-9.
-
1992: Mullen C A; Coale M M; Levy A T; Stetler-Stevenson W G; Liotta L A; Brandt S; Blaese R M
Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential.
Cancer research 1992;52(21):6020-4.
-
1992: Savarese D M; Russell J T; Fatatis A; Liotta L A
Type IV collagen stimulates an increase in intracellular calcium. Potential role in tumor cell motility.
The Journal of biological chemistry 1992;267(30):21928-35.
-
1992: Margulies I M; Höyhtyä M; Evans C; Stracke M L; Liotta L A; Stetler-Stevenson W G
Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1992;1(6):467-74.
-
1992: Stracke M L; Liotta L A
Multi-step cascade of tumor cell metastasis.
In vivo (Athens, Greece) 1992;6(4):309-16.
-
1992: Kohn E C; Sandeen M A; Liotta L A
In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates.
Cancer research 1992;52(11):3208-12.
-
1992: Fernandez P L; Merino M J; Nogales F F; Charonis A S; Stetler-Stevenson W; Liotta L
Immunohistochemical profile of basement membrane proteins and 72 kilodalton type IV collagenase in the implantation placental site. An integrated view.
Laboratory investigation; a journal of technical methods and pathology 1992;66(5):572-9.
-
1992: Campo E; Merino M J; Tavassoli F A; Charonis A S; Stetler-Stevenson W G; Liotta L A
Evaluation of basement membrane components and the 72 kDa type IV collagenase in serous tumors of the ovary.
The American journal of surgical pathology 1992;16(5):500-7.
-
1992: Stracke M L; Krutzsch H C; Unsworth E J; Arestad A; Cioce V; Schiffmann E; Liotta L A
Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.
The Journal of biological chemistry 1992;267(4):2524-9.
-
1992: Boike G; Lah T; Sloane B F; Rozhin J; Honn K; Guirguis R; Stracke M L; Liotta L A; Schiffmann E
A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells.
Melanoma research 1992;1(5-6):333-40.
-
1992: Templeton N S; Rodgers L A; Levy A T; Ting K L; Krutzsch H C; Liotta L A; Stetler-Stevenson W G
Cloning and characterization of a novel human cDNA that has DNA similarity to the conserved region of the collagenase gene family.
Genomics 1992;12(1):175-6.
-
1992: Stetler-Stevenson W G; Krutzsch H C; Liotta L A
TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
Matrix (Stuttgart, Germany). Supplement 1992;1():299-306.
-
1991: Liotta L A; Stetler-Stevenson W G
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
Cancer research 1991;51(18 Suppl):5054s-5059s.
-
1991: Stetler-Stevenson W G; Talano J A; Gallagher M E; Krutzsch H C; Liotta L A
Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment.
The American journal of the medical sciences 1991;302(3):163-70.
-
1991: Barnes R; Masood S; Barker E; Rosengard A M; Coggin D L; Crowell T; King C R; Porter-Jordan K; Wargotz E S; Liotta L A
Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival.
The American journal of pathology 1991;139(2):245-50.
-
1991: Leone A; Flatow U; King C R; Sandeen M A; Margulies I M; Liotta L A; Steeg P S
Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.
Cell 1991;65(1):25-35.
-
1991: Liotta L A; Stracke M L; Aznavoorian S A; Beckner M E; Schiffmann E
Tumor cell motility.
Seminars in cancer biology 1991;2(2):111-4.
-
1991: Levy A T; Cioce V; Sobel M E; Garbisa S; Grigioni W F; Liotta L A; Stetler-Stevenson W G
Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma.
Cancer research 1991;51(1):439-44.
-
1991: Cioce V; Castronovo V; Shmookler B M; Garbisa S; Grigioni W F; Liotta L A; Sobel M E
Increased expression of the laminin receptor in human colon cancer.
Journal of the National Cancer Institute 1991;83(1):29-36.
-
1991: Liotta L A; Steeg P S; Stetler-Stevenson W G
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.
Cell 1991;64(2):327-36.
-
1991: Castronovo V; Stetler-Stevenson W G; Sobel M E; Liotta L A
Molecular inhibition of cancer cell invasion and metastasis.
Princess Takamatsu symposia 1991;22():319-37.
-
1991: Stracke M L; Aznavoorian S A; Beckner M E; Liotta L A; Schiffmann E
Cell motility, a principal requirement for metastasis.
EXS 1991;59():147-62.
-
1991: Steeg P S; Bevilacqua G; Sobel M E; Liotta L A
Identification and characterization of differentially expressed genes in tumor metastasis: the nm23 gene.
Basic life sciences 1991;57():355-60; discussion 360-1.
-
1990: Beckner M E; Stracke M L; Liotta L A; Schiffmann E
Glycolysis as primary energy source in tumor cell chemotaxis.
Journal of the National Cancer Institute 1990;82(23):1836-40.
-
1990: Castronovo V; Colin C; Claysmith A P; Chen P H; Lifrange E; Lambotte R; Krutzsch H; Liotta L A; Sobel M E
Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy.
The American journal of pathology 1990;137(6):1373-81.
-
1990: Brown P D; Levy A T; Margulies I M; Liotta L A; Stetler-Stevenson W G
Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.
Cancer research 1990;50(19):6184-91.
-
1990: Templeton N S; Brown P D; Levy A T; Margulies I M; Liotta L A; Stetler-Stevenson W G
Cloning and characterization of human tumor cell interstitial collagenase.
Cancer research 1990;50(17):5431-7.
-
1990: Stetler-Stevenson W G; Brown P D; Onisto M; Levy A T; Liotta L A
Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues.
The Journal of biological chemistry 1990;265(23):13933-8.
-
1990: Kohn E C; Francis E A; Liotta L A; Schiffmann E
Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells.
International journal of cancer. Journal international du cancer 1990;46(2):287-92.
-
1990: Taraboletti G; Rao C N; Krutzsch H C; Liotta L A; Roberts D D
Sulfatide-binding domain of the laminin A chain.
The Journal of biological chemistry 1990;265(21):12253-8.
-
1990: Liotta L A; Steeg P S
Clues to the function of Nm23 and Awd proteins in development, signal transduction, and tumor metastasis provided by studies of Dictyostelium discoideum.
Journal of the National Cancer Institute 1990;82(14):1170-2.
-
1990: Aznavoorian S; Stracke M L; Krutzsch H; Schiffmann E; Liotta L A
Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells.
The Journal of cell biology 1990;110(4):1427-38.
-
1990: Liotta L A; Stetler-Stevenson W G
Metalloproteinases and cancer invasion.
Seminars in cancer biology 1990;1(2):99-106.
-
1990: Monteagudo C; Merino M J; San-Juan J; Liotta L A; Stetler-Stevenson W G
Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.
The American journal of pathology 1990;136(3):585-92.
-
1990: Liotta L A; Kohn E
Cancer invasion and metastases.
JAMA : the journal of the American Medical Association 1990;263(8):1123-6.
-
1990: Wacher M P; Krutzsch H C; Liotta L A; Stetler-Stevenson W G
Development of a novel substrate capture immunoassay for the detection of a neutral metalloproteinase capable of degrading basement membrane (type IV) collagen.
Journal of immunological methods 1990;126(2):239-45.
-
1990: Kohn E C; Liotta L A; Schiffmann E
Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells.
Biochemical and biophysical research communications 1990;166(2):757-64.
-
1990: Kohn E C; Liotta L A
L651582: a novel antiproliferative and antimetastasis agent.
Journal of the National Cancer Institute 1990;82(1):54-60.
-
1989: Stracke M L; Engel J D; Wilson L W; Rechler M M; Liotta L A; Schiffmann E
The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells.
The Journal of biological chemistry 1989;264(36):21544-9.
-
1989: Rosengard A M; Krutzsch H C; Shearn A; Biggs J R; Barker E; Margulies I M; King C R; Liotta L A; Steeg P S
Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development.
Nature 1989;342(6246):177-80.
-
1989: Stetler-Stevenson W G; Krutzsch H C; Liotta L A
Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.
The Journal of biological chemistry 1989;264(29):17374-8.
-
1989: Rao C N; Castronovo V; Schmitt M C; Wewer U M; Claysmith A P; Liotta L A; Sobel M E
Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor.
Biochemistry 1989;28(18):7476-86.
-
1989: Bevilacqua G; Sobel M E; Liotta L A; Steeg P S
Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.
Cancer research 1989;49(18):5185-90.
-
1989: Lah T T; Buck M R; Honn K V; Crissman J D; Rao N C; Liotta L A; Sloane B F
Degradation of laminin by human tumor cathepsin B.
Clinical & experimental metastasis 1989;7(4):461-8.
-
1989: Castronovo V; Taraboletti G; Liotta L A; Sobel M E
Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.
Journal of the National Cancer Institute 1989;81(10):781-8.
-
1989: Stetler-Stevenson W G; Krutzsch H C; Wacher M P; Margulies I M; Liotta L A
The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.
The Journal of biological chemistry 1989;264(3):1353-6.
-
1988: Steeg P S; Bevilacqua G; Pozzatti R; Liotta L A; Sobel M E
Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.
Cancer research 1988;48(22):6550-4.
-
1988: Guirguis R; Schiffmann E; Liu B; Birkbeck D; Engel J; Liotta L
Detection of autocrine motility factor in urine as a marker of bladder cancer.
Journal of the National Cancer Institute 1988;80(15):1203-11.
-
1988: Kalebic T; Williams J E; Talmadge J E; Kao-Shan C S; Kravitz B; Locklear K; Siegal G P; Liotta L A; Sobel M E; Steeg P S
A novel method for selection of invasive tumor cells: derivation and characterization of highly metastatic K1735 melanoma cell lines based on in vitro and in vivo invasive capacity.
Clinical & experimental metastasis 1988;6(4):301-18.
-
1988: Stracke M L; Kohn E C; Aznavoorian S A; Wilson L L; Salomon D; Krutzsch H C; Liotta L A; Schiffmann E
Insulin-like growth factors stimulate chemotaxis in human melanoma cells.
Biochemical and biophysical research communications 1988;153(3):1076-83.
-
1988: Roberts D D; Wewer U M; Liotta L A; Ginsburg V
Laminin-dependent and laminin-independent adhesion of human melanoma cells to sulfatides.
Cancer research 1988;48(12):3367-73.
-
1988: Liotta L A
Gene products which play a role in cancer invasion and metastasis.
Breast cancer research and treatment 1988;11(2):113-24.
-
1988: Steeg P S; Bevilacqua G; Kopper L; Thorgeirsson U P; Talmadge J E; Liotta L A; Sobel M E
Evidence for a novel gene associated with low tumor metastatic potential.
Journal of the National Cancer Institute 1988;80(3):200-4.
-
1988: Liotta L A
Oncogene induction of metastases.
Ciba Foundation symposium 1988;141():94-108.
-
1988: Pozzatti R; McCormick M; Thompson M A; Garbisa S; Liotta L; Khoury G
Regulation of the metastatic phenotype by the E1A gene of adenovirus-2.
Advances in experimental medicine and biology 1988;233():293-301.
-
1988: Garbisa S; Negro A; Kalebic T; Pozzatti R; Muschel R; Saffiotti U; Liotta L A
Type IV collagenolytic activity linkage with the metastatic phenotype induced by ras transfection.
Advances in experimental medicine and biology 1988;233():179-86.
-
1988: Liotta L A; Wewer U; Rao N C; Schiffmann E; Stracke M; Guirguis R; Thorgeirsson U; Muschel R; Sobel M
Biochemical mechanisms of tumor invasion and metastases.
Advances in experimental medicine and biology 1988;233():161-9.
-
1988: Liotta L A; Wewer U; Rao N C; Schiffmann E; Stracke M; Guirguis R; Thorgeirsson U; Muschel R; Sobel M
Biochemical mechanisms of tumor invasion and metastases.
Progress in clinical and biological research 1988;256():3-16.
-
1987: Taraboletti G; Roberts D D; Liotta L A
Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains.
The Journal of cell biology 1987;105(5):2409-15.
-
1987: Wewer U M; Taraboletti G; Sobel M E; Albrechtsen R; Liotta L A
Role of laminin receptor in tumor cell migration.
Cancer research 1987;47(21):5691-8.
-
1987: Liotta L A; Wewer U; Rao N C; Schiffmann E; Stracke M; Guirguis R; Thorgeirsson U; Muschel R; Sobel M
Biochemical mechanisms of tumor invasion and metastasis.
Anti-cancer drug design 1987;2(2):195-202.
-
1987: Guirguis R; Margulies I; Taraboletti G; Schiffmann E; Liotta L
Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration.
Nature 1987;329(6136):261-3.
-
1987: Stracke M L; Guirguis R; Liotta L A; Schiffmann E
Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells.
Biochemical and biophysical research communications 1987;146(1):339-45.
-
1987: Garbisa S; Pozzatti R; Muschel R J; Saffiotti U; Ballin M; Goldfarb R H; Khoury G; Liotta L A
Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.
Cancer research 1987;47(6):1523-8.
-
1987: Liotta L A; Guirguis R; Stracke M
Biology of melanoma invasion and metastasis.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 1987;1(1):5-15.
-
1986: Wewer U M; Liotta L A; Jaye M; Ricca G A; Drohan W N; Claysmith A P; Rao C N; Wirth P; Coligan J E; Albrechtsen R
Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(19):7137-41.
-
1986: Muschel R J; Nakahara K; Chu E; Pozzatti R; Liotta L A
Karyotypic analysis of diploid or near diploid metastatic Harvey ras transformed rat embryo fibroblasts.
Cancer research 1986;46(8):4104-8.
-
1986: Pozzatti R; Muschel R; Williams J; Padmanabhan R; Howard B; Liotta L; Khoury G
Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials.
Science (New York, N.Y.) 1986;232(4747):223-7.
-
1986: Liotta L A; Guirguis R A; Schiffmann E
Tumor autocrine motility factor.
Progress in clinical and biological research 1986;212():17-24.
-
1986: Liotta L A; Rao C N; Wewer U M
Biochemical interactions of tumor cells with the basement membrane.
Annual review of biochemistry 1986;55():1037-57.
-
1984: Barsky S H; Rao N C; Restrepo C; Liotta L A
Immunocytochemical enhancement of basement membrane antigens by pepsin: applications in diagnostic pathology.
American journal of clinical pathology 1984;82(2):191-4.
-
1984: Liotta L A; Rao N C; Barsky S H; Bryant G
The laminin receptor and basement membrane dissolution: role in tumour metastasis.
Ciba Foundation symposium 1984;108():146-62.
-
1983: Rao N C; Barsky S H; Terranova V P; Liotta L A
Isolation of a tumor cell laminin receptor.
Biochemical and biophysical research communications 1983;111(3):804-8.
-
1983: Liotta L A; Rao N C; Terranova V P; Barsky S; Thorgeirsson U
Tumor cell attachment and degradation of basement membranes.
Symposium on Fundamental Cancer Research 1983;36():169-76.
Sign-in to see more